| David King, PHARMD | |
|
204 W Lincoln Ave, Lincoln, KS 67455-1920 | |
| (785) 524-2629 | |
| Not Available |
| Full Name | David King |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 204 W Lincoln Ave, Lincoln, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427544527 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-105938 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David King, PHARMD 204 W Lincoln Ave, Lincoln, KS 67455-1920 Ph: () - | David King, PHARMD 204 W Lincoln Ave, Lincoln, KS 67455-1920 Ph: (785) 524-2629 |
News Archive
The dietary concerns of too much fructose is well documented. High-fructose corn syrup has become the sweetener most commonly added to processed foods. Many dietary experts believe this increase directly correlates to the nation's growing obesity epidemic. Now, new research at Oregon Health & Science University demonstrates that the brain - which serves as a master control for body weight - reacts differently to fructose compared with another common sweetener, glucose.
Researchers at the University of Washington have used a noninvasive light-based imaging technology to literally see inside the living brain, providing a new tool to study how diseases like dementia, Alzheimer's, and brain tumors change brain tissue over time.
Sorin Group announced today the first inclusion of a patient in the Clepsydra clinical trial. The study will investigate the sensitivity to changes in heart failure status of PhD™, a unique diagnostic feature using the dual sensor technology of minute ventilation and accelerometer to monitor patient's breathing and activity levels every day.
Friday September 2, 2011 the AMA released new Current Procedural Terminology (CPT) codes that will be reported by hospitals, physicians and ambulatory centers providing coverage for additional treatment options for cancer patients.
Solazyme, Inc., the renewable oil production company and leader in algal synthetic biology, has been selected by the U.S. Department of Defense (DoD) to research, develop, and demonstrate commercial scale production of algae-derived advanced biofuel that meets the United States Navy's rigorous specifications for military tactical platforms.
› Verified 6 days ago
Dr. April Diane Coover, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 W Lincoln Ave, Lincoln, KS 67455 Phone: 785-524-4649 Fax: 785-524-3402 |